Filter
957
Filtered Results: 957
Text search:
pharmaceutical
regulatory
authority
Featured
Recommendations
78
New Publications
285
Language
Document type
No document type
477
Studies & Reports
178
Guidelines
148
Manuals
60
Strategic & Response Plan
57
Fact sheets
15
Training Material
9
Situation Updates
8
Resource Platforms
3
Brochures
1
Infographics
1
Countries / Regions
Kenya
41
Ethiopia
37
India
32
Uganda
27
Global
26
South Africa
24
Ghana
21
Liberia
21
Nigeria
20
Namibia
20
Rwanda
18
Tanzania
18
Sierra Leone
16
Bangladesh
16
Zambia
16
Malawi
15
Nepal
14
Western and Central Europe
14
Ukraine
11
Zimbabwe
10
Syria
9
Africa
9
Cambodia
9
Myanmar / Burma
9
Lesotho
8
Philippines
8
Eastern Europe
8
Botswana
8
Latin America and the Carribbean
6
South–East Asia Region
6
West and Central Africa
5
Indonesia
5
Eswatini/ Swaziland
5
Congo, Democratic Republic of
4
Western Pacific Region
4
East and Southern Africa
4
Thailand
3
Benin
3
Albania
3
Burkina Faso
3
Guinea
3
Jordan
3
Middle East and North Africa
3
Eastern Europe and Central Asia
3
Pakistan
3
Cameroon
2
Laos
2
Senegal
2
Mozambique
2
USA
2
Haiti
2
Asia
2
United Kingdom
2
North Macedonia
1
Tajikistan
1
Timor Leste/ East Timor
1
Australia
1
China
1
Iran
1
Fiji
1
Afghanistan
1
Germany
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
Lebanon
1
Vietnam
1
Papua New Guinea
1
Moldova
1
Russia
1
Egypt
1
Sudan
1
Central African Republic
1
Mali
1
Chad
1
Iraq
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
426
Clinical Guidelines
58
Key Resources
36
Public Health
35
Pharmacy & Technologies
29
Women & Child Health
24
Capacity Building
4
Toolboxes
AMR
124
Pharmacy
118
COVID-19
54
HIV
40
TB
40
Mental Health
31
Rapid Response
23
Global Health Education
20
Planetary Health
19
NTDs
15
Ebola & Marburg
14
Caregiver
14
Conflict
14
Health Financing Toolbox
13
NCDs
11
Malaria
11
Specific Hazards
10
2.0 Rapid Response
10
Polio
5
Refugee
2
Natural Hazards
2
Disability
2
Zika
2
Social Ethics
1
The purpose of the PAS III is to guide Pakistan’s overall national response for HIV and AIDS through 2020, through focused interventions with set targets, costs, roles and responsibilities. The successful implementation of PAS III involves multiple stakeholders to achieve priority outcomes outline...
Despite the considerable improvement in global health, millions of people still lack access to quality health services, including access to effective antimicrobial medicines, or are impoverished as a result of health spending. At the same time, antimicrobial resistance – a consequence of overuse a...
Conflict, climate change, the COVID-19 pandemic, and the economic effects of the Ukraine crisis are interacting to create new and worsen existing hunger hotspots, reversing the gains families had made to escape poverty.
В борьбе с туберкулезом достигнуты значительные прорывы, среди которых ускоренные и более точные методы диагностики и первые новые лекарственные средства за 50 л...
The document, "Progress on the Prevention and Control of Non-Communicable Diseases," reports on global efforts to reduce the impact of NCDs, such as heart disease, cancer, diabetes, and chronic respiratory diseases, following the commitments made at high-level United Nations meetings. It highlights ...
This guide provides a comprehensive overview of essential information related to immunization, including technical information about vaccines, a review of immunization program management best practices, guidance on the delivery of immunization services, monitoring and evaluation, disease surveillanc...
Textes du Codex concernant la résistance aux antimicrobiens d’origine alimentaire
Textos del Codex sobre la resistencia a los antimicrobianos transmitida por los alimentos
Antimicrobial resistance (AMR) is a major global public health concern and a food safety issue. When pathogens become r...
NSP Review
Engaging with South Africa’s National Strategic Plan for HIV, STIs and TB Edition 7 July – August 2013
A publication of the Treatment Action Campaign and SECTION27
GeneXpert: An imperfect rollout
TB in South African prisons: Where to now?
Decentralising DR-TB care: How far alon...
Accessed on 04.04.2023
The Drugs for Neglected Diseases initiative (DNDi) is an international
non-profit organization that discovers, develops, and delivers safe,
effective, and affordable treatments for the most neglected patients
Asthma is the most common noncommunicable disease in children, and among the most common in adults. According to the most recent estimates from the Global Asthma Network Phase I study, around one in 10 children and adults have symptoms of asthma and one in 20 school-aged children have severe asthma ...
9 September 2020
In a snapshot, fair allocation of vaccines will occur in the following way:
An initial proportional allocation of doses to countries until all countries reach enough quantities to cover 20% of their population
This document is also available in Arabic | Chinese | French | R...
This Joint Emergency Management Plan of the International Organizations (Joint Plan) describes the
interagency framework of preparedness for and response to an actual, potential or perceived nuclear or
radiological emergency independent of whether it arises from an acci...
